According to a research report by CITIC Securities, the National Healthcare Security Administration has rolled out a fresh policy. This policy establishes a framework for pricing and service project setup pertaining to surgical robots and surgical consumables. Such a strategic move is anticipated to significantly expedite the widespread adoption and promotion of surgical robots across China. Furthermore, the Administration has made it clear that the scope of the service project setup guidelines will be progressively broadened in the coming years. This expansion is poised to create ample development opportunities for a greater variety of innovative medical device products.

In light of these developments, CITIC Securities is encouraging investors to keep a close eye on the investment prospects within the medical industry chain. The report delineates two primary investment themes. The first theme centers around the surgical robot sector, encompassing its upstream and downstream industry chains. The second theme directs attention towards high-value consumable industries, with a particular focus on areas such as minimally invasive surgery and orthopedics.